Trial intelligence / Profile preview

Active versus expectant management of term pre-labour rupture of membranes in Enugu, Nigeria

PACTR202509717423392Recruiting

Sponsor
Nweze Anthony Victor
Start
Jan 2025
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of misoprostol and oxytocin in Rupture of amniotic membranes (PROM), sponsored by Nweze Anthony Victor. Started Jan 2025; status: recruiting.

02

Drugs

misoprostoloxytocin
03

Conditions

Rupture of amniotic membranes (PROM)

Beyond the preview

Go deeper on PACTR202509717423392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202509717423392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call